Summary
- Current Price
- As of today, CPRX price is $31.45, up +0.03% on
- Current Price All-Time High
- CPRX price is currently -3.41% below its historical high of $32.56 set on
- Market Cap
- CPRX current market cap is $4B, up +46.66% over the past 365 days
- PE Ratio
- CPRX current PE ratio is 18.08
- Revenue
- CPRX current annual revenue is $588.99M, up +19.78% year-over-year
- Next Earnings
- The next earnings release for CPRX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Catalyst Pharmaceuticals, Inc. |
| Ticker | NASDAQ: CPRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | catalystpharma.com |
| Employees | 181 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $31.45 | |
| Price, 1D Change | +0.03% | |
| $4B | ||
| - | ||
| 18.08 | ||
| 0.70 | ||
| $589M | ||
| Revenue, 1Y Change | +19.78% | |
| $1.68 | ||
| EPS, 1Y Change | +28.40% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $1.68 | ||
| EPS Estimate | N/A | $3.17 |
| EPS Est. Change | N/A | +88.46% |
| $588.99M | ||
| Revenue Estimate | N/A | $636.20M |
| Revenue Est. Change | N/A | +8.02% |
| Current Price | $31.45 | |
| Price Target | - | $31.50 |
| Price Tgt. Change | - | +0.16% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.06 | $1.31 | -36.25% | |
| $2.54 | $1.68 | -33.73% | |
| $3.17 | N/A | +88.46% | |
| $3.18 | N/A | +88.88% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $484.10M | $491.73M | +1.58% | |
| $579.13M | $588.99M | +1.70% | |
| $636.20M | N/A | +8.02% | |
| $717.90M | N/A | +21.89% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $31.45 | |
| $24.95 | ||
| $30.72 | ||
| $26.16 | ||
| $30.23 | ||
| $0.24 | ||
| 0.70 | ||
| $0.11 | ||
| 70.17 | ||
| 1.67% | ||
| 32.40% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $588.99M | ||
| $1.68 | ||
| $464.24M | ||
| 78.82% | ||
| $257.78M | ||
| 43.77% | ||
| $214.33M | ||
| 36.39% | ||
| $295.95M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 6.08 | ||
| 5.82 | ||
| - | ||
| 6 | ||
| 17.85 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 18.08 | ||
| 6.45 | ||
| 3.80 | ||
| 10.11 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $954.27M | ||
| $709.17M | ||
| $1.11B | ||
| $894.03M | ||
| $152.54M | ||
| $147.15M | ||
| $2.79M | ||
| $437.00K | ||
| $11.20M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $374.66M | ||
| $206.46M | ||
| $124.75M | ||
| $0.00 | ||
| $38.17M | ||
| $0.00 | ||
| $69.19M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $208.67M | ||
| -$58.00K | ||
| -$16.99M | ||
| $58.00K | ||
| $208.61M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Citigroup | → | |
| Stephens & Co. | → | |
| Citigroup | → | |
| Citigroup | → | |
| Baird | → | |
| HC Wainwright & Co. | → | |
| Stephens & Co. | → | |
| Baird | ||
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with CPRX
FAQ
What is the ticker symbol for Catalyst Pharmaceuticals, Inc.?
The ticker symbol for Catalyst Pharmaceuticals, Inc. is NASDAQ:CPRX
Does Catalyst Pharmaceuticals, Inc. pay dividends?
No, Catalyst Pharmaceuticals, Inc. does not pay dividends
What sector is Catalyst Pharmaceuticals, Inc. in?
Catalyst Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Catalyst Pharmaceuticals, Inc. in?
Catalyst Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Catalyst Pharmaceuticals, Inc. based in?
Catalyst Pharmaceuticals, Inc. is headquartered in United States
When did Catalyst Pharmaceuticals, Inc. go public?
Catalyst Pharmaceuticals, Inc. initial public offering (IPO) was on November 8, 2006
Is Catalyst Pharmaceuticals, Inc. in the S&P 500?
No, Catalyst Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Catalyst Pharmaceuticals, Inc. in the NASDAQ 100?
No, Catalyst Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Catalyst Pharmaceuticals, Inc. in the Dow Jones?
No, Catalyst Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Catalyst Pharmaceuticals, Inc. last earnings report?
Catalyst Pharmaceuticals, Inc.'s most recent earnings report was on May 11, 2026
When does Catalyst Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Catalyst Pharmaceuticals, Inc. is August 5, 2026
Data Sources & References
- CPRX Official Website catalystpharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1369568/000119312526071525/0001193125-26-071525-index.htm
- CPRX Profile on Yahoo Finance finance.yahoo.com/quote/CPRX
- CPRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cprx